These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2205260)

  • 1. Soluble recombinant CD4--a potential therapeutic agent for HIV infection.
    Rosenberg M; Bugelski PJ; Fong KL; Drutz DJ; Sweet RW; Webb DD
    Biotherapy; 1990; 2(2):107-18. PubMed ID: 2205260
    [No Abstract]   [Full Text] [Related]  

  • 2. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
    Daar ES; Li XL; Moudgil T; Ho DD
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6574-8. PubMed ID: 2395859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4-targeted immune intervention: a strategy for the therapy of AIDS and autoimmune disease.
    Auffray C; Piatier-Tonneau D; Kroemer G
    Trends Biotechnol; 1991 Apr; 9(4):124-31. PubMed ID: 1367392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.
    Ashkenazi A; Smith DH; Marsters SA; Riddle L; Gregory TJ; Ho DD; Capon DJ
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7056-60. PubMed ID: 1871120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity.
    Watanabe M; Boyson JE; Lord CI; Letvin NL
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5103-7. PubMed ID: 1594618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
    Cordell J; Moore JP; Dean CJ; Klasse PJ; Weiss RA; McKeating JA
    Virology; 1991 Nov; 185(1):72-9. PubMed ID: 1718090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
    Kahn JO; Allan JD; Hodges TL; Kaplan LD; Arri CJ; Fitch HF; Izu AE; Mordenti J; Sherwin JE; Groopman JE
    Ann Intern Med; 1990 Feb; 112(4):254-61. PubMed ID: 2297204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4.
    Daar ES; Ho DD
    Am J Med; 1991 Apr; 90(4A):22S-26S. PubMed ID: 2018048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
    DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
    Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anti-human immunodeficiency virus effect of recombinant CD4-immunoglobulin in vitro: a good candidate for AIDS treatment.
    Chowdhury IH; Koyanagi Y; Takamatsu K; Yoshida O; Kobayashi S; Yamamoto N
    Med Microbiol Immunol; 1991; 180(4):183-92. PubMed ID: 1784269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4.
    Newman R; Alberts J; Anderson D; Carner K; Heard C; Norton F; Raab R; Reff M; Shuey S; Hanna N
    Biotechnology (N Y); 1992 Nov; 10(11):1455-60. PubMed ID: 1369023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.
    Kuritzkes DR; Jacobson J; Powderly WG; Godofsky E; DeJesus E; Haas F; Reimann KA; Larson JL; Yarbough PO; Curt V; Shanahan WR
    J Infect Dis; 2004 Jan; 189(2):286-91. PubMed ID: 14722894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response.
    Watanabe M; Levine CG; Shen L; Fisher RA; Letvin NL
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4616-20. PubMed ID: 2052546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism for the T4 lymphopenia of AIDS.
    Micali S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10982-3. PubMed ID: 7902577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
    Nowak J
    Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prospects for using immunoadsorption in AIDS therapy].
    Shmatkov BA; Kulaev DV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 May; (5):24-7. PubMed ID: 1882622
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
    Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H
    Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling interleukin-2-based immunotherapy in AIDS pathogenesis.
    Joly M; Odloak D
    J Theor Biol; 2013 Oct; 335():57-78. PubMed ID: 23806696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.